Ucb
Sort by
1 items
-
MarketWatch - Business
Biogen and Belgian partner UCB announce positive data from late-stage trial of lupus treatment
Biogen Inc.’s stock rose 2% early Tuesday, after the company and Belgian partner UCB announced positive results in a late-stage trial5 hours ago